INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![20 20 onsite]( "High Density, Low Availability: Rethinking Ophthalmic Trial Readiness")
High Density, Low Availability: Rethinking Ophthalmic Trial ReadinessThe adoption of mobile ophthalmic solutions and collaboration with specialized vendors is recommended to ensure trial consistency and reach underserved regions.
-
![Solution-GettyImages-1060711170]( "10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them")
10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves ThemVendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.
-
![GettyImages-2152658176 oncology, doctor, patient]( "How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?")
How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?By directing radioactive isotopes straight to diseased tissue, these agents deliver potent, localized treatment while sparing healthy cells — a major leap forward for patients with metastatic or treatment-resistant cancers.
-
![Professional employees discussing ideas of project on tablet pc iStock-836658296]( "Site Perspectives On BYOD ePRO Use")
Site Perspectives On BYOD ePRO UseThis study examines participant convenience and compliance, aiming to understand and address the challenges faced by site personnel in global trials.
-
Harnessing The Potential Of Patient-Level Data In Clinical Trials6/19/2024
Join our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.
-
Finding The Right CRO Partner For Early-Stage Oncology Trials11/21/2025
Discover how a data-driven CRO selection framework can replace manual processes, minimize bias, and build stronger, more collaborative sponsor–vendor relationships.
-
Key Risk Areas that Can Derail Clinical Trials with Ocular Endpoints1/15/2025
By embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.
-
South Korea And Australia On The Rise As Clinical Research Hubs7/3/2024
Novotech’s vice president emphasizes the expanding clinical presence in the APAC region, with a focus on Australia and South Korea.
-
Navigating The Complexities Of Clinical Trial Site Payments Forecasting7/9/2024
Advanced technology and best practices have the potential to revolutionize clinical trial site payment forecasting, leading to significant improvements in overall trial efficiency and management.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-1435226184 data]( "APAC Biopharma: Bridge The Gap To The US FDA")
Uncover how these regulatory and partner/outsource services are invaluable for biopharma innovators in navigating the U.S. FDA regulatory process.
-
![10 Steps To Better Alzheimer’s Disease Research]( "Biorasi Rare and Urgent Disease")
Read how Biorasi's speed and agility make all the difference in overcoming unique obstacles to rare disease clinical trials.
-
![GettyImages-1012405368 biotech]( "Earn The Trust Of Biotechs And Emerging Pharma")
Backed by a global team of more than 3,000 professionals across 34 office locations, we deliver scalable, high-quality clinical development solutions tailored to the needs of emerging and mid-sized biotech companies.
-
![GettyImages-1169928112-patient-doctor-medicine-pill-capsule-tablet-OSD-oral]( "The Next Generation Of Oral Targeted Therapies")
Solve the unique challenges of poorly soluble molecules like targeted protein degraders (TPDs), such as PROTACs and molecular glues, seamlessly accelerating your molecule from development to commercialization.
-
![Gene therapy iStock-1177162185]( "Cell And Gene Therapies")
Accelerate your cell or gene therapeutic to market with tailored clinical and regulatory strategies and expert insights.
